Long-Term Efficacy and Safety of Nilutamide Plus Castration in Advanced Prostate Cancer, and the Significance of Early Prostate Specific Antigen Normalization-Reference-Cited by-同舟云学术

Long-Term Efficacy and Safety of Nilutamide Plus Castration in Advanced Prostate Cancer, and the Significance of Early Prostate Specific Antigen Normalization

Published:1997-07 Issue:1 Volume:158 Page:160-163
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Dijkman Gerhard A.¹,Janknegt Rudi A.¹,De Reijke Theo M.¹,Debruyne Frans M.J.¹

Affiliation:

1. The International Anandron Study Group; From the Department of Urology, University Hospital Nijmegen, Nijmegen, The Netherlands.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference23 articles.

1. Therapy of metastatic prostate carcinoma by orchiectomy plus anandron versus orchiectomy plus placebo. Initial results of a randomized multicenter study.;Knonagel;Helv. Chir. Acta.,1989

2. Total androgen blockade vs orchiectomy in stage D prostate cancer;Brisset,1987

3. DHT in prostate cancer tissue-a guide to management and therapy.;Geller;Prostate,1985

4. Endocrine therapy for prostate cancer.;Labrie;Endocr. Metab. Clin. N. Amer.,1991

5. A controlled trial of castration with and without nilutamide in metastatic prostatic carcinoma.;Beland;Cancer,1990

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. QSRR Modeling of Lipophilicity of New Spirohydantoin Derivatives Determined with Various TLC Systems;Acta Chimica Slovenica;2024-06-20

2. Targeting signaling pathways in prostate cancer: mechanisms and clinical trials;Signal Transduction and Targeted Therapy;2022-06-24

3. A review of clinical evidence to assess differences in efficacy and safety of luteinizing hormone–releasing hormone (LHRH) agonist (goserelin) and LHRH antagonist (degarelix);Indian Journal of Cancer;2022

4. Gonadotropin-releasing hormone agonists in prostate cancer: A comparative review of efficacy and safety;Indian Journal of Cancer;2022

5. Efficacy and Safety of Non-Steroidal Anti-Androgens in Patients with Metastatic Prostate Cancer: Meta-Analysis of Randomized Controlled Trials;Reviews on Recent Clinical Trials;2020-02-14